Literature DB >> 27736776

Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery.

Pardeep Kumar1, F Matthew Kuhlmann1, Kirandeep Bhullar2, Hyungjun Yang2, Bruce A Vallance2, Lijun Xia3, Qingwei Luo1, James M Fleckenstein4,5,6.   

Abstract

At present, there is no vaccine for enterotoxigenic Escherichia coli (ETEC), an important cause of diarrheal illness. Nevertheless, recent microbial pathogenesis studies have identified a number of molecules produced by ETEC that contribute to its virulence and are novel antigenic targets to complement canonical vaccine approaches. EtpA is a secreted two-partner adhesin that is conserved within the ETEC pathovar. EtpA interacts with the tips of ETEC flagella to promote bacterial adhesion, toxin delivery, and intestinal colonization by forming molecular bridges between the bacteria and the epithelial surface. However, the nature of EtpA interactions with the intestinal epithelium remains poorly defined. Here, we demonstrate that EtpA interacts with glycans presented by transmembrane and secreted intestinal mucins at epithelial surfaces to facilitate pathogen-host interactions that culminate in toxin delivery. Moreover, we found that a major effector molecule of ETEC, the heat-labile enterotoxin (LT), may enhance these interactions by stimulating the production of the gel-forming mucin MUC2. Our studies suggest, however, that EtpA participates in complex and dynamic interactions between ETEC and the gastrointestinal mucosae in which host glycoproteins promote bacterial attachment while simultaneously limiting the epithelial engagement required for effective toxin delivery. Collectively, these data provide additional insight into the intricate nature of ETEC interactions with the intestinal epithelium that have potential implications for rational approaches to vaccine design.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27736776      PMCID: PMC5116737          DOI: 10.1128/IAI.00692-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model.

Authors:  Koushik Roy; David Hamilton; Marguerite M Ostmann; James M Fleckenstein
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

2.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.

Authors:  Malin E V Johansson; Mia Phillipson; Joel Petersson; Anna Velcich; Lena Holm; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

Review 3.  Biosynthesis of intestinal mucins: MUC1, MUC2, MUC3 and more.

Authors:  B J Van Klinken; K M Tytgat; H A Büller; A W Einerhand; J Dekker
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

4.  EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin.

Authors:  Pardeep Kumar; Qingwei Luo; Tim J Vickers; Alaullah Sheikh; Warren G Lewis; James M Fleckenstein
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

5.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Cholera toxin stimulates secretion of immunoreactive intestinal mucin.

Authors:  J F Forstner; N W Roomi; R E Fahim; G G Forstner
Journal:  Am J Physiol       Date:  1981-01

7.  Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.

Authors:  Eric Houpt; Lisa Barroso; Lauren Lockhart; Rhonda Wright; Carole Cramer; David Lyerly; William A Petri
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

8.  Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells.

Authors:  Amber M Johnson; Radhey S Kaushik; David H Francis; James M Fleckenstein; Philip R Hardwidge
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

9.  Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.

Authors:  Firdausi Qadri; Amit Saha; Tanvir Ahmed; Abdullah Al Tarique; Yasmin Ara Begum; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

10.  Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.

Authors:  Qingwei Luo; Tim J Vickers; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more
  15 in total

Review 1.  Enterotoxigenic Escherichia coli Infections.

Authors:  James M Fleckenstein; F Matthew Kuhlmann
Journal:  Curr Infect Dis Rep       Date:  2019-03-04       Impact factor: 3.725

2.  Confronting challenges to enterotoxigenic Escherichia coli vaccine development.

Authors:  James M Fleckenstein
Journal:  Front Trop Dis       Date:  2021-09-24

3.  Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway.

Authors:  Ganapathy A Subramenium; Subrata Sabui; Jonathan S Marchant; Hamid M Said; Veedamali S Subramanian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

Review 4.  Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.

Authors:  Jian Fang; Hui Wang; Yuping Zhou; Hui Zhang; Huiting Zhou; Xiaohong Zhang
Journal:  Exp Mol Med       Date:  2021-05-17       Impact factor: 8.718

5.  Virulence and transcriptome profile of multidrug-resistant Escherichia coli from chicken.

Authors:  Hafiz I Hussain; Zahid Iqbal; Mohamed N Seleem; Deyu Huang; Adeel Sattar; Haihong Hao; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.

Authors:  Alaullah Sheikh; Rasheduzzaman Rashu; Yasmin Ara Begum; F Matthew Kuhlman; Matthew A Ciorba; Scott J Hultgren; Firdausi Qadri; James M Fleckenstein
Journal:  PLoS Negl Trop Dis       Date:  2017-05-22

7.  Interplay of a secreted protein with type IVb pilus for efficient enterotoxigenic Escherichia coli colonization.

Authors:  Hiroya Oki; Kazuki Kawahara; Takahiro Maruno; Tomoya Imai; Yuki Muroga; Shunsuke Fukakusa; Takaki Iwashita; Yuji Kobayashi; Shigeaki Matsuda; Toshio Kodama; Tetsuya Iida; Takuya Yoshida; Tadayasu Ohkubo; Shota Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

8.  Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection.

Authors:  Subhra Chakraborty; Arlo Randall; Tim J Vickers; Doug Molina; Clayton D Harro; Barbara DeNearing; Jessica Brubaker; David A Sack; A Louis Bourgeois; Philip L Felgner; Xiaowu Liang; Sachin Mani; Heather Wenzel; R Reid Townsend; Petra E Gilmore; Michael J Darsley; David A Rasko; James M Fleckenstein
Journal:  NPJ Vaccines       Date:  2019-08-28       Impact factor: 7.344

9.  Tracking Bioluminescent ETEC during In vivo BALB/c Mouse Colonization.

Authors:  Gerardo E Rodea; Francisco X Montiel-Infante; Ariadnna Cruz-Córdova; Zeus Saldaña-Ahuactzi; Sara A Ochoa; Karina Espinosa-Mazariego; Rigoberto Hernández-Castro; Juan Xicohtencatl-Cortes
Journal:  Front Cell Infect Microbiol       Date:  2017-05-16       Impact factor: 5.293

Review 10.  Review of Newly Identified Functions Associated With the Heat-Labile Toxin of Enterotoxigenic Escherichia coli.

Authors:  Qiangde Duan; Pengpeng Xia; Rahul Nandre; Weiping Zhang; Guoqiang Zhu
Journal:  Front Cell Infect Microbiol       Date:  2019-08-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.